Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xtacy Therapeutics (XTCYF)
OTHER OTC:XTCYF
Xtacy Therapeutics (XTCYF) Stock Price & Analysis
4 Followers
XTCYF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.21
Previous Close$0.1
Volume1.64K
Average Volume (3M)37.04K
Market Cap
$1.60M
Enterprise Value$1.60M
Total Cash (Recent Filing)C$0.00
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-1.50
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding54,576,471
10 Day Avg. Volume2,100
30 Day Avg. Volume37,039
Standard Deviation0.48
R-Squared0.00013
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)-6.55
Price to Sales (P/S)152.79
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Xtacy Therapeutics News
PremiumCompany Announcements
Xtacy Therapeutics Optimizes Finances with Equity
PremiumCompany Announcements
Xtacy Therapeutics Advances with Debt Settlement and Research
PremiumCompany Announcements
Xtacy Therapeutics Resolves Filing Delay
PremiumCompany Announcements
Xtacy Therapeutics Extends Management Trading Ban
PremiumCompany Announcements
Xtacy Therapeutics Reports on MCTO Status
PremiumCompany Announcements
Xtacy Therapeutics Reports Filing Delay and MCTOOptions Prices
Currently, No data available
---
Ownership Overview
36.25%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
63.75% Public Companies and
Individual Investors
XTCYF FAQ
What was Xtacy Therapeutics’s price range in the past 12 months?
Xtacy Therapeutics lowest stock price was <$0.01 and its highest was $0.21 in the past 12 months.
What is Xtacy Therapeutics’s market cap?
Currently, no data Available
When is Xtacy Therapeutics’s upcoming earnings report date?
Xtacy Therapeutics’s upcoming earnings report date is Aug 28, 2024 which is in 33 days.
How were Xtacy Therapeutics’s earnings last quarter?
Currently, no data Available
Is Xtacy Therapeutics overvalued?
According to Wall Street analysts Xtacy Therapeutics’s price is currently Overvalued.
Does Xtacy Therapeutics pay dividends?
Xtacy Therapeutics does not currently pay dividends.
What is Xtacy Therapeutics’s EPS estimate?
Xtacy Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xtacy Therapeutics have?
Xtacy Therapeutics has 54,576,470 shares outstanding.
What happened to Xtacy Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Xtacy Therapeutics?
Currently, no hedge funds are holding shares in XTCYF
---
Xtacy Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
15.73%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
197.99%
Trailing 12-Months
Company Description
Xtacy Therapeutics
Redfund Capital Corp is a debt financing company. The company provides debt financing facility to help companies build their valuation and get to the next level in its financing cycle without giving away equity prematurely in their growth cycle. It is focusing on providing finance to medical cannabis, hemp, and CBD-related, healthcare-related target companies.
---
Technical Analysis
---